TNF-related apoptosis-inducing ligand (TRAIL) induces osteoclast differentiation from monocyte/macrophage lineage precursor cells.

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Molecular Immunology

• Publication date

  2008-04-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.molimm.2007.12.003PMID 18206242
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Brief Definitive Report : Osteoclast differentiation independent of the TRANCE-RANK-TRAF6 axis

  2006cited by this paper
• Hepatitis C Virus Core Protein Modulates TRAIL-Mediated Apoptosis by Enhancing Bid Cleavage and Activation of Mitochondria Apoptosis Signaling Pathway1

  2005cited by this paper
• Osteoclast differentiation independent of the TRANCE–RANK–TRAF6 axis

  2005cited by this paper
• Mechanistic insight into osteoclast differentiation in osteoimmunology

  2005cited by this paper
• Interaction of Fas Ligand and Fas Expressed on Osteoclast Precursors Increases Osteoclastogenesis1

  2005cited by this paper
• The role of the immune system in the pathophysiology of osteoporosis

  2005cited by this paper
• M-CSF mediates TNF-induced inflammatory osteolysis.

  2005cited by this paper
• TNF-related apoptosis-inducing ligand (TRAIL) blocks osteoclastic differentiation induced by RANKL plus M-CSF.

  2004cited by this paper
• Decoy receptor 3 (DcR3) induces osteoclast formation from monocyte/macrophage lineage precursor cells

  2004cited by this paper
• The TNF receptor superfamily

  2003cited by this paper
• Osteoclast differentiation and activation

  2003cited by this paper
• p38 Mitogen-activated protein kinase is crucially involved in osteoclast differentiation but not in cytokine production, phagocytosis, or dendritic cell differentiation of bone marrow macrophages.

  2003cited by this paper
• Biology of the TRANCE axis.

  2003cited by this paper
• Clinicopathologic Features and Factors Related to Survival of Patients with Small Hepatocellular Carcinoma after Hepatic Resection

  2003cited by this paper
• Osteoprotegerin protects against generalized bone loss in tumor necrosis factor-transgenic mice.

  2003cited by this paper
• The phosphatidylinositol 3-kinase, p38, and extracellular signal-regulated kinase pathways are involved in osteoclast differentiation.

  2002cited by this paper
• U0126 and PD98059, Specific Inhibitors of MEK, Accelerate Differentiation of RAW264.7 Cells into Osteoclast-like Cells*

  2002cited by this paper
• Induction of TRAIL-mediated glioma cell death by human T cells.

  2002cited by this paper
• TRAIL expression by activated human CD4(+)V alpha 24NKT cells induces in vitro and in vivo apoptosis of human acute myeloid leukemia cells.

  2001cited by this paper
• TRAIL (Apo2 Ligand) and TWEAK (Apo3 Ligand) Mediate CD4+ T Cell Killing of Antigen-Presenting Macrophages1

  2000cited by this paper
• Involvement of p38 mitogen-activated protein kinase signaling pathway in osteoclastogenesis mediated by receptor activator of NF-kappa B ligand (RANKL).

  2000cited by this paper
• Involvement of p38 Mitogen-activated Protein Kinase Signaling Pathway in Osteoclastogenesis Mediated by Receptor Activator of NF-κB Ligand (RANKL)*

  2000cited by this paper
• OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis

  1999cited by this paper
• Human osteoclasts derive from CD14‐positive monocytes

  1999cited by this paper
• Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand

  1999cited by this paper
• Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation.

  1998cited by this paper
• TRAIL: a molecule with multiple receptors and control mechanisms.

  1998cited by this paper
• Osteoprotegerin Is a Receptor for the Cytotoxic Ligand TRAIL*

  1998cited by this paper
• A combination of osteoclast differentiation factor and macrophage-colony stimulating factor is sufficient for both human and mouse osteoclast formation in vitro.

  1998cited by this paper
• Death receptor 5, a new member of the TNFR family, and DR4 induce FADD-dependent apoptosis and activate the NF-kappaB pathway.

  1997cited by this paper
• Cloning and Characterization of TRAIL-R3, a Novel Member of the Emerging TRAIL Receptor Family

  1997cited by this paper
• Origin of osteoclasts: mature monocytes and macrophages are capable of differentiating into osteoclasts under a suitable microenvironment prepared by bone marrow-derived stromal cells.

  1990cited by this paper

• TNF-Related Apoptosis-Inducing Ligand: Non-Apoptotic Signalling

  2024cites this paper
• The role of secreted osteoclastogenic factor of activated T cells in bone remodeling

  2022cites this paper
• Concerted regulation of OPG/RANKL/ NF‑κB/MMP-13 trajectories contribute to ameliorative capability of prodigiosin and/or low dose γ-radiation against adjuvant- induced arthritis in rats.

  2022cites this paper
• Salvianolate Ameliorates Osteopenia and Improves Bone Quality in Prednisone-Treated Rheumatoid Arthritis Rats by Regulating RANKL/RANK/OPG Signaling

  2021cites this paper
• TRAIL receptor-induced features of epithelial-to-mesenchymal transition increase tumour phenotypic heterogeneity: potential cell survival mechanisms

  2020cites this paper
• The multifaceted role of TRAIL signaling in cancer and immunity

  2020cites this paper
• Osteoclast Multinucleation: Review of Current Literature

  2020cites this paper
• Upregulation of circulating inflammatory biomarkers under the influence of periodontal disease in rheumatoid arthritis patients.

  2020cites this paper
• Multiple Interactions Between Cancer Cells and the Tumor Microenvironment Modulate TRAIL Signaling: Implications for TRAIL Receptor Targeted Therapy

  2019cites this paper
• University of Groningen Multiple Interactions Between Cancer Cells and the Tumor Microenvironment Modulate TRAIL Signaling

  2019cites this paper
• TRAIL inhibits RANK signaling and suppresses osteoclast activation via inhibiting lipid raft assembly and TRAF6 recruitment

  2019cites this paper
• In vitro cell models of vascular calcification: integrative roles for RANKL and TRAIL

  2018cites this paper
• Radix Paeoniae Rubra stimulates osteoclast differentiation by activation of the NF-κB and mitogen-activated protein kinase pathways

  2018cites this paper
• Cell death‐independent activities of the death receptors CD95, TRAILR1, and TRAILR2

  2017cites this paper
• TAK1 inhibition subverts the osteoclastogenic action of TRAIL while potentiating its antimyeloma effects.

  2017cites this paper
• TRAIL facilitates cytokine expression and macrophage migration during hypoxia/reoxygenation via ER stress‐dependent NF‐&kgr;B pathway

  2017cites this paper
• Microgravity Induction of TRAIL Expression in Preosteoclast Cells Enhances Osteoclast Differentiation

  2016cites this paper
• In vitro evaluation of the biological effect of SOFAT on osteoblasts.

  2015cites this paper
• Contribution of osteoclasts to the bone–tumor niche

  2015cites this paper
• Regulation and function of Rankl in arterial calcification.

  2014cites this paper
• L'hyperthermie provoque l'agrégation de FLIP et restaure l'apoptose induite par TRAIL

  2014cites this paper
• TRAIL-induced kinases activation and apoptosis: towards improved death receptor targeted therapy for lung cancer

  2013cites this paper
• Non-canonical kinase signaling by the death ligand TRAIL in cancer cells: discord in the death receptor family

  2013cites this paper
• Expression of TRAIL and its receptors DR5 and DcR2 in orthodontic tooth movement.

  2013cites this paper
• The two directions of TNF-related apoptosis-inducing ligand in rheumatoid arthritis.

  2013cites this paper
• Differentiation of human osteosarcoma 3AB-OS stem-like cells in derivatives of the three primary germ layers as a useful in vitro model to develop several purposes

  2013cites this paper
• TRAF-6 Dependent Signaling Pathway Is Essential for TNF-Related Apoptosis-Inducing Ligand (TRAIL) Induces Osteoclast Differentiation

  2012cites this paper
• Mutual role of PGRN/TNF-α on osteopenia developing in obesity's inflammation state.

  2012cites this paper
• Regulating TRAIL Receptor-Induced Cell Death at the Membrane: A Deadly Discussion

  2011cites this paper
• TRAIL-induced keratinocyte differentiation requires caspase activation and p63 expression.

  2011cites this paper
• TRAIL effect on osteoclast formation in physiological and pathological conditions.

  2011cites this paper
• TRAIL produced from multiple myeloma cells is associated with osteolytic markers.

  2011cites this paper
• Ribosome inactivating protein B-chain induces osteoclast differentiation from monocyte/macrophage lineage precursor cells.

  2011cites this paper
• TRAIL-R4 Promotes Tumor Growth and Resistance to Apoptosis in Cervical Carcinoma HeLa Cells through AKT

  2011cites this paper
• The impact of inflammation on bone mass in children

  2011influential citation
• Lipopolysaccharide‐induced expression of TRAIL promotes dendritic cell differentiation

  2010cites this paper
• Pathway-Based Association Analyses Identified TRAIL Pathway for Osteoporotic Fractures

  2010cites this paper
• Regulation of osteoprotegerin pro- or anti-tumoral activity by bone tumor microenvironment.

  2010cites this paper
• Oral malodorous compound induces osteoclast differentiation without receptor activator of nuclear factor κB ligand.

  2010cites this paper
• Tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) induces chemotactic migration of monocytes via a death receptor 4-mediated RhoGTPase pathway.

  2010cites this paper
• Osteoclast Differentiation and Function

  2009cites this paper
• Where ends the TRAIL in arthritis

  2009cites this paper
• Bax deficiency in mice increases cartilage production during fracture repair through a mechanism involving increased chondrocyte proliferation without changes in apoptosis.

  2008cites this paper